MENZIUSO RICHARD THOMAS — SEC insider filings
SEC reporting owner CIK 2156820. 2 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2026-10-02 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | Principal Accounting Officer | 2 | — | — | 2 |
Insider filings — MENZIUSO RICHARD THOMAS
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 3 | Altimmune, Inc. (ALT) | Holdings only — no transactions reported | EDGAR |
| 2026-10-02 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 84,546 (derivative) @ $0 · Grant/award (A): 36,234 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2023-05-19 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2156820 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →